🚀 VC round data is live in beta, check it out!
Dis-Chem Pharmacies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dis-Chem Pharmacies and similar public comparables like Omnicell, LBX Pharmacy, Redcare Pharmacy, AiN Group and more.
Dis-Chem Pharmacies Overview
About Dis-Chem Pharmacies
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
Founded
1978
HQ
Employees
20.6K
Website
Sectors
Financials (LTM)
EV
$2B
Dis-Chem Pharmacies Financials
Dis-Chem Pharmacies reported last 12-month revenue of $3B and EBITDA of $203M.
In the same LTM period, Dis-Chem Pharmacies generated $587M in gross profit, $203M in EBITDA, and $72M in net income.
Revenue (LTM)
Dis-Chem Pharmacies P&L
In the most recent fiscal year, Dis-Chem Pharmacies reported revenue of $2B and EBITDA of $194M.
Dis-Chem Pharmacies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $587M | XXX | $518M | XXX | XXX | XXX |
| Gross Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $203M | XXX | $194M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $72M | XXX | $69M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $176M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Dis-Chem Pharmacies Stock Performance
Dis-Chem Pharmacies has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Dis-Chem Pharmacies' stock price is $2.14.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -1.7% | XXX | XXX | XXX | $0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDis-Chem Pharmacies Valuation Multiples
Dis-Chem Pharmacies trades at 0.8x EV/Revenue multiple, and 10.5x EV/EBITDA.
EV / Revenue (LTM)
Dis-Chem Pharmacies Financial Valuation Multiples
As of March 20, 2026, Dis-Chem Pharmacies has market cap of $2B and EV of $2B.
Equity research analysts estimate Dis-Chem Pharmacies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dis-Chem Pharmacies has a P/E ratio of 25.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 10.5x | XXX | 11.0x | XXX | XXX | XXX |
| EV/EBIT | 16.2x | XXX | 18.3x | XXX | XXX | XXX |
| EV/Gross Profit | 3.6x | XXX | 4.1x | XXX | XXX | XXX |
| P/E | 25.5x | XXX | 26.4x | XXX | XXX | XXX |
| EV/FCF | 35.7x | XXX | (72.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dis-Chem Pharmacies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Dis-Chem Pharmacies Margins & Growth Rates
Dis-Chem Pharmacies' revenue in the last 12 month grew by 10%.
Dis-Chem Pharmacies' revenue per employee in the last FY averaged $0.1M.
Dis-Chem Pharmacies' rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dis-Chem Pharmacies' rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Dis-Chem Pharmacies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Dis-Chem Pharmacies Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Omnicell | XXX | XXX | XXX | XXX | XXX | XXX |
| LBX Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| AiN Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Create SD Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dis-Chem Pharmacies M&A Activity
Dis-Chem Pharmacies acquired XXX companies to date.
Last acquisition by Dis-Chem Pharmacies was on XXXXXXXX, XXXXX. Dis-Chem Pharmacies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Dis-Chem Pharmacies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDis-Chem Pharmacies Investment Activity
Dis-Chem Pharmacies invested in XXX companies to date.
Dis-Chem Pharmacies made its latest investment on XXXXXXXX, XXXXX. Dis-Chem Pharmacies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Dis-Chem Pharmacies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dis-Chem Pharmacies
| When was Dis-Chem Pharmacies founded? | Dis-Chem Pharmacies was founded in 1978. |
| Where is Dis-Chem Pharmacies headquartered? | Dis-Chem Pharmacies is headquartered in South Africa. |
| How many employees does Dis-Chem Pharmacies have? | As of today, Dis-Chem Pharmacies has over 20K employees. |
| Who is the CEO of Dis-Chem Pharmacies? | Dis-Chem Pharmacies' CEO is Rui Manuel Morais. |
| Is Dis-Chem Pharmacies publicly listed? | Yes, Dis-Chem Pharmacies is a public company listed on Johannesburg Stock Exchange. |
| What is the stock symbol of Dis-Chem Pharmacies? | Dis-Chem Pharmacies trades under DCP ticker. |
| When did Dis-Chem Pharmacies go public? | Dis-Chem Pharmacies went public in 2016. |
| Who are competitors of Dis-Chem Pharmacies? | Dis-Chem Pharmacies main competitors are Omnicell, LBX Pharmacy, Redcare Pharmacy, AiN Group. |
| What is the current market cap of Dis-Chem Pharmacies? | Dis-Chem Pharmacies' current market cap is $2B. |
| What is the current revenue of Dis-Chem Pharmacies? | Dis-Chem Pharmacies' last 12 months revenue is $3B. |
| What is the current revenue growth of Dis-Chem Pharmacies? | Dis-Chem Pharmacies revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Dis-Chem Pharmacies? | Current revenue multiple of Dis-Chem Pharmacies is 0.8x. |
| Is Dis-Chem Pharmacies profitable? | Yes, Dis-Chem Pharmacies is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dis-Chem Pharmacies? | Dis-Chem Pharmacies' last 12 months EBITDA is $203M. |
| What is Dis-Chem Pharmacies' EBITDA margin? | Dis-Chem Pharmacies' last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Dis-Chem Pharmacies? | Current EBITDA multiple of Dis-Chem Pharmacies is 10.5x. |
| What is the current FCF of Dis-Chem Pharmacies? | Dis-Chem Pharmacies' last 12 months FCF is $60M. |
| What is Dis-Chem Pharmacies' FCF margin? | Dis-Chem Pharmacies' last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Dis-Chem Pharmacies? | Current FCF multiple of Dis-Chem Pharmacies is 35.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.